StockData

Picard Medical vs Beyond Air

PMI and XAIR side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How PMI and XAIR compare

Picard Medical is the larger company, worth 8.4 times as much as Beyond Air ($16.2M against $1.9M).

Beyond Air grew revenue faster over the last twelve months (60.7% versus 11.6% for Picard Medical).

Picard Medical keeps more of each dollar of sales as profit, with a net margin of −371% compared with −436% at Beyond Air.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricPMIXAIR
Size and price
Market cap$16.2M$1.9M
Share price$6.91$2.01
Change, 1 year−94.9%−92.7%
Change, 5 years–−100.0%
Beta (5Y)−2.18−0.20
Employees7554
StockData Score
Total score66
Valuation score03 (better)
Growth score22
Performance score00
Health score4 (better)1
Dividend score00
Valuation
P/S3.0×0.3× (better)
P/B12.2×1.0× (better)
FCF yield–−1018%
Fair value$3.92$12.88
Margin of safety−76.5%84.4% (better)
Growth
Revenue growth (TTM)11.6%60.7% (better)
Revenue growth, 5Y average–54.5%
Profitability
Gross margin26.2% (better)4.2%
Operating margin−267% (better)−365%
Net margin−371% (better)−436%
FCF margin–−255%
Return on equity−426% (better)−562%
Return on invested capital−351%–
Financial health
Debt / equity0.00–
Interest coverage–−6.3×
Current ratio0.993.31 (better)
Altman Z-score−17.62−15.90 (better)
Piotroski F-score56 (better)
Dividends and buybacks
Buyback yield0.00%–
Shareholder yield0.00%0.00%
Ownership
Held by institutions6.5%7.2%
Insider net buying, 12 months–$287K

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.